According to the joint motion, both parties expect that FDA's response to NPA's citizen petition on the matter will resolve the drug preclusion-related case.
The brief continued to argue that a preliminary injunction should prevent New York’s supplement age restriction from going into effect until the lawsuit ends.
The appeal challenges interpretations which led to the recent U.S. District Court decision to let the law go into effect ahead of the lawsuit’s conclusion.
A new House bill would amend the Food, Drug, and Cosmetic Act to grant FDA more authority against products that don't meet the definition of dietary supplement.
The latest of what will be several guidance documents on the NDI process provides updates on the agency’s proposed method to handle proprietary information.
Majority Whip expressed concern about products adulterated with tianeptine, noting an increase in adverse events associated with ‘gas station heroin.’